Josh Pherigo at GHP used data to look into what tech specialties are thriving in Houston — and what niches have shown promising growth. Photo via LinkedIn

When you look at Houston's venture capital investment patterns, what do they tell you? To Josh Pherigo, research director of data analytics at the Greater Houston Partnership, it paints a picture of what tech and startup niches are thriving.

Based on PitchBook data, Pherigo put together an analysis of what industries within Houston are attracting the most investments. The study came out of the fact that Houston's hold on oil and gas is going to shift as the industry goes through the energy transition. Since O&G is such a crucial part of Houston's economy, the city will have to see a rise in new industries to remain competitive with its economy.

"The idea was to look at the innovation ecosystem and see what the technologies are that are doing well here at at attracting VC funding," Pherigo says on the Houston Innovators Podcast. "And by seeing how well certain technologies are doing, we'll be able to see if these are some areas that have some natural competitive advantages in Houston's economy that we can then use to spur growth in the next few decades — and even just out of the recession we're in right now."

The report found that life science and oil and gas currently attract the most VC investments in Houston, but Pherigo found potential in a few other industries like B2B payments technology — Houston-based fintech startup, HighRadius recently raised $125 million.

The study, which also compared Houston to Austin and Dallas, found that there was a cleantech war emerging between Austin and Houston. While Houston's ecosystem has a greater presence of cleantech startups, Austin cleantech is still bringing in more VC investments. However, in Houston, between new corporate incubators and Greentown Labs entering Houston, the city is creating a lot of infrastructure for this industry.

"It's going to be interesting over the next few years to see how Houston can position itself as the leader in Texas for this, because they are going to have a lot of competition from Austin," Pherigo says.

Pherigo goes into more detail about what he found interesting in the report, and even dives into what the data shows for the future of Houston's tech specialties in the episode of the podcast. You can listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.